Axio Biosolutions has announced its strategic decision to enter the retail space in India. Axio is set to make its best-in-class wound care and Covid essential products available for Indian homes across 50 cities in the next one year.

The B2C / D2C move is aimed at consolidating the company’s leadership position in the global advanced wound care space. Funded by Ratan Tata, Omidyar Network, Accel and Chiratae Ventures, Axio has seen exponential growth in the international markets in the last few years. With its patented and US FDA approved product, Axiostat– that stops uncontrollable bleeding within a few minutes of its application– Axio has the distinction of being the only company in Asia and among the top five global companies with the unique bleeding-control technology. With its presence in over 18 countries across the globe, Axiostat is the only ‘Made-in-India’ product to compete in the global market.

With Axio’s entry into retail, consumers will now have access to world-class products such as :

• ASK+ Kits –  that consist of  Axiostat and other first-aid dressings that stop uncontrollable bleeding.
• MaxioCel – an advanced wound care dressing to provide comfort and faster healing to patients suffering from chronic wounds, such as pressure ulcers, diabetic foot ulcers, venous leg ulcers, post-operative surgical wounds and cavity wounds, among others
• RESIST+ – Covid essentials manufactured in compliance with WHO standards and pharma regulations. Products in this range include surgical disinfectants, hand sanitisers, multi-surface disinfectant sprays, and alcohol sanitising wipes among others.

Commenting on the company’s latest development, Leo Mavely, CEO and Founder, Axio Biosolutions, said, “In an era of teleconsultations, democratisation of critical care products can elevate the overall health and safety ecosystem in the country.”

In addition to the products being available on the company’s online store (www.axiobiostore.com), Axio has partnered with over 6,000+ brick-and-mortar stores as well as popular e-commerce platforms, such as Flipkart, Amazon, Moglix, to deliver its products directly to the end consumer.

Axio Biosolutions has its corporate office in Bengaluru and a GMP, ISO 13485-certified manufacturing facility in Gujarat.